Figure 3.
Kaplan–Meier survival analysis among 71 patients with epithelial ovarian cancer according to expression of GSK-3α/β and pGSK-3α/βTyr279/216.
Notes: Patients with high expression (++ − +++) of GSK-3α/β (A) or pGSK-3α/βTyr279/216 (B) had a significantly inferior overall survival time than those with low expression (P=0.004, P=0.005, respectively).
Abbreviation: GSK, glycogen synthase kinase.